Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Nature Medicine
|
February 7, 2025
Allogeneic approach unlocks CAR T cell benefits in solid tumors
Rozalyn Chok, Sneha Ramakrishna
Nature Medicine
|
November 24, 2020
Using single-cell analysis to predict CAR T cell outcomes
Sneha Ramakrishna, Nirali N Shah
Blood
|
February 28, 2020
Supercharging your CAR
Sneha Ramakrishna, Kara L Davis
Expert Opinion on Biological Therapy
|
March 4, 2020
Prospects and challenges for use of CAR T cell therapies in solid tumors
Sneha Ramakrishna, Valentin Barsan, Crystal Mackall
Current Oncology Reports
|
January 31, 2020
Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
Valentin Barsan, Sneha Ramakrishna, Kara L Davis
Molecular Therapy. Oncology
|
April 23, 2026
CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities
Kun-Wei Song, Aanchal Preet Kaur, Sneha Ramakrishna
The Journal of Biological Chemistry
|
April 9, 2005
The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature
Il-Man Kim, Sneha Ramakrishna, Galina A Gusarova, et al.
Pediatric Blood & Cancer
|
April 10, 2026
Docetaxel-Induced Myositis in a 16-Year-Old Male With Rhabdomyosarcoma: Case Report and Literature Review
Rohaum Hamidi, Katherine E Masih, Audrey Nisbet, et al.
The Journal of Biological Chemistry
|
September 8, 2005
Functional characterization of evolutionarily conserved DNA regions in forkhead box f1 gene locus
Il-Man Kim, Yan Zhou, Sneha Ramakrishna, et al.
JACC. Cardiooncology
|
August 16, 2021
Use of Chimeric Antigen Receptor Modified T Cells With Extensive Leukemic Myocardial Involvement
Brian Han, Raul Montiel-Esparza, Henry Chubb, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Nature Medicine
|
February 7, 2025
Allogeneic approach unlocks CAR T cell benefits in solid tumors
Rozalyn Chok, Sneha Ramakrishna
Nature Medicine
|
November 24, 2020
Using single-cell analysis to predict CAR T cell outcomes
Sneha Ramakrishna, Nirali N Shah
Blood
|
February 28, 2020
Supercharging your CAR
Sneha Ramakrishna, Kara L Davis
Expert Opinion on Biological Therapy
|
March 4, 2020
Prospects and challenges for use of CAR T cell therapies in solid tumors
Sneha Ramakrishna, Valentin Barsan, Crystal Mackall
Current Oncology Reports
|
January 31, 2020
Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
Valentin Barsan, Sneha Ramakrishna, Kara L Davis
Molecular Therapy. Oncology
|
April 23, 2026
CAR T cells for pediatric CNS tumors: Clinical experience and reverse translational opportunities
Kun-Wei Song, Aanchal Preet Kaur, Sneha Ramakrishna
The Journal of Biological Chemistry
|
April 9, 2005
The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature
Il-Man Kim, Sneha Ramakrishna, Galina A Gusarova, et al.
Pediatric Blood & Cancer
|
April 10, 2026
Docetaxel-Induced Myositis in a 16-Year-Old Male With Rhabdomyosarcoma: Case Report and Literature Review
Rohaum Hamidi, Katherine E Masih, Audrey Nisbet, et al.
The Journal of Biological Chemistry
|
September 8, 2005
Functional characterization of evolutionarily conserved DNA regions in forkhead box f1 gene locus
Il-Man Kim, Yan Zhou, Sneha Ramakrishna, et al.
JACC. Cardiooncology
|
August 16, 2021
Use of Chimeric Antigen Receptor Modified T Cells With Extensive Leukemic Myocardial Involvement
Brian Han, Raul Montiel-Esparza, Henry Chubb, et al.
Page
of 4